Repair Stem Cell Institute Says Stanford University’s Stem Cell Study Confirms the Futility of Embryonics in Human Therapy

August 26, 2008

The Repair Stem Cell Institute LLC (RSCI; http://www.RepairSemCells.org) reported today that Stanford University School of Medicine’s recent discovery there may be limitations to the effectiveness of human therapies derived from embryonic stem cells (ESC) because the cells injected in mice stimulated the kind of immune rejection seen with transplanted organs clearly delivers a blow to proponents of embryonic stem cell research who continue to ballyhoo the promise of ESC when in effect, as the Stanford study showed, the transplanted stem cells were dead within about seven to 10 days.Earthtimes)